Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-27T02:11:54.133Z Has data issue: false hasContentIssue false
  • English
  • Français

An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4–18 years and in people aged 65 years and over, in two national British surveys

Published online by Cambridge University Press:  02 January 2007

Christopher J Bates ,
Kristina D Pentieva  and
Ann Prentice
Christopher J Bates*
Affiliation:
MRC Human Nutrition Research, Downhams Lane, Milton Road, Cambridge CB4 1XJ, UK
Kristina D Pentieva
Affiliation:
MRC Human Nutrition Research, Downhams Lane, Milton Road, Cambridge CB4 1XJ, UK
Ann Prentice
Affiliation:
MRC Human Nutrition Research, Downhams Lane, Milton Road, Cambridge CB4 1XJ, UK
*
*Corresponding author: Email chris.bates@mrc-hnr.cam.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

To compare vitamin B6 status indices with each other and with potential confounding factors, in the datasets from two national British surveys and associated studies.

Design:

Vitamin B6 status was measured by plasma pyridoxal phosphate (PLP) and plasma pyridoxic acid (PA) in both surveys, and also by erythrocyte aspartate aminotransferase activation coefficient (EAATAC) in one of the surveys. Plasma α1-antichymotrypsin was measured as an index of acute phase status; plasma creatinine was measured as an index of renal function; and plasma total alkaline phosphatase activity was measured as a proxy for PLP hydrolase activity.

Setting:

The survey of people aged 65 years and over was carried out in 80 postcode sectors across mainland Britain during 1994–95 and the survey of young people was carried out in 132 postcode sectors across mainland Britain during 1997.

Subjects:

Blood samples from c. 1000 subjects of both sexes in each survey permitted measurements of plasma PLP and PA. There were also measurements of EAATAC in the young people's survey.

Results:

According to published limits of normality, only 5% or less of the young people had unacceptable vitamin B6 status as measured by plasma PLP. About half had apparently unacceptable status by EAATAC, but this observation is difficult to interpret. The young people had considerably higher plasma concentrations of PLP and lower concentrations of PA than the older people. In both surveys, plasma PLP was strongly correlated with plasma PA and in the young persons’ survey it was also correlated, although much less strongly, with the basal activity and activation coefficient of aspartate aminotransferase. Both plasma PLP and EAATAC (but not PA nor basal aspartate aminotransferase activity) were influenced by acute phase status in young people, as indicated by significant correlations with α1-antichymotrypsin. In people aged 65 years and over, PA (but not PLP) was correlated with renal function, as indicated by its relation with plasma creatinine; however PLP (but not PA) was correlated with plasma alkaline phosphatase activity.

Conclusions:

Several potential confounders — acute phase reaction, kidney malfunction and hydrolase activity — may influence vitamin B6 status indices, although differently for different indices and different age groups. Since older people have relatively poor vitamin B6 status, which may have important health implications for them, more reliable vitamin B6 status indices are needed.

Keywords

Vitamin B6 statusPyridoxal phosphatePyridoxic acidAspartate aminotransferaseConfoundersBritish surveys
Type
Research Article
Information
Public Health Nutrition , Volume 2 , Issue 4 , April 1999 , pp. 529 - 535
Copyright
Copyright © CABI Publishing 1999

References

1Driskell, JA. Vitamin B-6 requirements in humans. Nutr. Res. 1994; 14: 293–324.CrossRefGoogle Scholar
2Leklem, JE. Vitamin B6. In: Shils, ME, Olson, JA, Shike, M, eds. Modern Nutrition in Health and Disease. Philadelphia: Lea and Febiger, 1994; 383–93.Google Scholar
3Schultz, TD, Leklem, JE. Urinary 4-pyridoxic acid, urinary vitamin B-6 and plasma pyridoxal phosphate as measures of vitamin B-6 status and dietary intake in adults. In: Leklem, JE, Reynolds, RD, eds. Methods in Vitamin B-6 Nutrition. New York: Plenum Press, 1981; 297–320.CrossRefGoogle Scholar
4Löwik, MHR, van den Berg, H, Westenbrink, S, Wedel, M, Schrijver, J, Ockhuizen, T. Dose-response relationships regarding vitamin B-6 in elderly people: a nationwide nutritional survey (Dutch Nutritional Surveillance System). Am. J. Clin. Nutr. 1989; 50: 391–9.CrossRefGoogle ScholarPubMed
5Rse, CS, Gyorgy, P, Butler, M, et al. Age differences in vitamin B6 status of 617 men. Am. J. Clin. Nutr. 1976; 29: 847–53.CrossRefGoogle Scholar
6Löwik, MRH, van den Berg, H, Schrijver, J, Odink, J, Wedel, M, van Houten, P. Marginal nutritional status among institutionalised elderly women as compared to those living more independently (Dutch Nutrition Surveillance System). J. Am. Coll. Nutr. 1992; 11: 673–81.Google Scholar
7Finch, S, Doyle, W, Lowe, C, et al. National Diet and Nutrition Survey: People Aged 65 Years or Over. Vol. 1. Report of the Diet and Nutrition Survey. London: SO, 1998.Google Scholar
8Gregory, J, et al. National Diet and Nutrition Survey: Young People Aged 4–18 years. Vol. 1. Report of the Diet and Nutrition Survey. London: SO, in preparation.Google Scholar
9Bates, CJ, Pentieva, KD, Prentice, A, Mansoor, MA, Finch, S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 or over. Br. J. Nutr. 1999; 81: 191–201.Google Scholar
10Vuilleumier, JP, Keller, HE, Keck, E. Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part III: The apoenzyme stimulation tests for vitamins B1, B2 and B6 adapted to the Cobas-Bio analyzer. Int. J. Vitam. Nutr. Res. 1990; 60: 126–35.Google Scholar
11Bates, CJ, Pentieva, KD, Matthews, N, Macdonald, A. A simple, sensitive and reproducible assay for pyridoxal phosphate in human plasma. Clin. Chim. Acta 1999; 280: 101–11.CrossRefGoogle ScholarPubMed
12Euronut SENECA Investigators. Nutritional status: blood vitamins A, E, B6, B12, folic acid and carotene. Eur. J. Clin. Nutr. 1991; 45: 63–82.Google Scholar
13Van Poppel, G, Schneijder, P, Löwik, MRH, Schrijver, J, Kok, FJ. Nutritional status and food consumption in 10–11 year old Dutch boys (Dutch Nutrition Surveillance System). Br. J. Nutr. 1991; 66: 161–9.Google Scholar
14Driskell, JA, Moak, SW. Plasma pyridoxal phosphate concentrations and coenzyme stimulation of erythrocyte alanine aminotransferase activities of white and black adolescent girls. Am. J. Clin. Nutr. 1986; 43: 599–603.Google Scholar
15Southon, S, Wright, AJA, Finglas, PM, Bailey, AL, Loughridge, JM, Walker, AD. Dietary intake and micronutrient status of adolescents: effect of vitamin and trace element supplementation on indices of status and performance in test of verbal and non-verbal intelligence. Br. J. Nutr. 1994; 71: 897–918.Google Scholar
16Leklem, JE. Vitamin B6. In: Machlin, LJ, ed. Handbook of Vitamins, 2nd edn.New York: Marcel Dekker, 1991; 341–92.Google Scholar
17Willett, WC. Does low vitamin B6 intake increase the risk of coronary disease? In: Reynolds, RD, Leklem, JE, eds. Vitamin B6: Its Role in Health and Disease. New York: Alan R Liss, 1985; 337–46.Google Scholar
18Robinson, K, Arheart, K, Refsum, H, et al. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease and coronary artery disease. Circulation 1998; 97: 437–43.Google Scholar
19Folsom, AR, Nieto, FJ, McGovon, PG, et al. Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Homocysteine, Related Genetic Polymorphisms, and B Vitamins. The Atherosclerosis Risk in Communities (ARIC) Study, 1998.Google Scholar
20Talbott, MC, Miller, LT, Kerkvliet, NI. Pyridoxine supplementation: effect of lymphocyte responses in elderly persons. Am. J. Clin. Nutr. 1987; 46: 659–64.CrossRefGoogle ScholarPubMed
21Riggs, KM, Spiro, A III, Tucker, K, Rush, D. Relations of vitamin B-12, vitamin B-6, folate and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 1996; 63: 306–14.CrossRefGoogle ScholarPubMed
22Calvin, J, Neale, G, Fotherby, KJ, Price, CP. The relative merits of acute phase proteins in the recognition of inflammatory conditions. Ann. Clin. Biochem. 1988; 25: 60–6.Google Scholar
23Coburn, SP, Whyte, MP. Role of phosphatases in the regulation of vitamin B-6 metabolism in hypophosphatasia and other disorders. In: Leklem, JE, Reynolds, RD, eds. Clinical and Physiological Application of Vitamin B-6. New York: Alan R Liss, 1988; 65–94.Google Scholar
24Iqbal, SJ, Brain, A, Reynolds, TM, Penny, M, Holland, S. Relationship between serum alkaline phosphatase and pyridoxal-5′-phosphate levels in hypophosphatasia. Clin. Sci. 1998; 94: 203–6.CrossRefGoogle ScholarPubMed
25Brussaard, JH, Löwik, MHR, van den Berg, H, Brants, HAM, Kistemaker, C. Micronutrient status with special to vitamin B6. Eur. J. Clin. Nutr. 1997; 51(Suppl. 3): S32–8.Google Scholar
26Van den Berg, H. Vitamin B6 status and requirements in older adults. Br. J. Nutr. 1999; 81: 175–6.Google Scholar